Patsnap adds Scheduled Tasks to Patsnap Eureka
Users can run recurring research daily, on weekdays, weekly or monthly, receiving an emailed summary while full reports with linked patents stay in Eureka.
See the latest news and media coverage for Patsnap. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-native intelligence platform for IP, R&D, and life sciences
patsnap.comLast updated
In short: Patsnap launched drug-patent AI agents; media reported a confidential Hong Kong-Singapore IPO filing.
Users can run recurring research daily, on weekdays, weekly or monthly, receiving an emailed summary while full reports with linked patents stay in Eureka.
Patsnap's Life Sciences and Patent MCPs are now available in BenchSci’s EMET. Scientists can query patent and drug data directly within the research environment.
The tool drafts and revises patent applications directly within Microsoft Word, handling claims and descriptions for various patent offices.
The tool identifies structures in PDFs and images, links results to source figures, and ensures traceability for medicinal chemistry workflows.
Patsnap, an intellectual-property data provider, has filed confidentially for an initial public offering in Hong Kong and Singapore, snapping a prolonged drought for technology listings by Southeast Asian companies.
[SINGAPORE] Patsnap, an intellectual-property data provider, is mulling a dual listing in Hong Kong and Singapore, according to people familiar with the matter.
PatSnap prepares for the next phase of growth to further scale the adoption of its innovation intelligence platform, which powers R&D and IP teams developing...
TOKYO -- PatSnap, a Singapore developer of software that helps companies analyze patent information, said on Wednesday it raised $300 million from a group of...
Track Patsnap and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Patsnap and other trending companies.